Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


2nd Reverse Phase Protein Array Global Workshop

12 Nov 2012 - 13 Nov 2012 - Edinburgh, Scotland, UK



Bookmark and Share


Key Workstreams;

  • Challenges, needs, advantages and disadvantages associated with printing and detection
  • Image acquisition, data processing and normalization
  • Validating and sharing of Antibody data
  • Alignment with "Proteomics Standard Initiative" (PSI) at HUPO
  • New technologies showcase
  • Pharmaceutical Discovery applications
  • RPPA in management and analysis of clinical samples
  • How to use RPA Data in the Clinic (i.e. PD Marker, Prognostic Marker and Predictive Marker):
  • Launch : Global RPPA Society


The evolution of Reverse Phase Protein Array (RPPA ) technologies has facilitated the application of high-throughput functional proteomics in patient samples and preclinical drug screening with improved sensitivity and quantification to support the identification and analysis of post-translational biomarkers and pathway networks.

Advancing RPPA technology into mainstream basic research, drug discovery and clinical diagnostics applications will require improved consistency in methods and an expanded portfolio of validated antibody reagents and procedures that can be shared across the community.

Hosted by the University of Edinburgh, the second Reverse Phase Protein Array Global Workshop will bring together scientists from both academia and industry to discuss the latest technical advances and standards for generating and analysing results using Reverse Phase Protein Arrays.

The 2012 workshop shall also be used to launch a global RPPA society to support communication, data-sharing and ambitions of the RPPA community.



Further information
Scientific News
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
The Spice of Life
Scientists discover important genetic source of human diversity.
Removing Race from Human Genetic Research
A group of scientists are urging their colleagues to take a step forward and stop using racial categories when researching and studying human genetics.
Tick Genome Reveals Secrets of a Successful Bloodsucker
NIH-funded study could lead to new tick control methods.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!